Subcutaneous Infliximab After A Previous Intravenous Dose Optimization

NCT06113913 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

275

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Diseases
Crohn Disease
Ulcerative Colitis

Interventions

DRUG: Infliximab
DRUG: Infliximab
DRUG: Infliximab

Sponsor

Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW

Collaborators

[object Object]